Tuesday Thirteen Inc. - Net Worth and Insider Trading
Tuesday Thirteen Inc. Net Worth
The estimated net worth of Tuesday Thirteen Inc. is at least $0 dollars as of 2024-09-21. Tuesday Thirteen Inc. is the 10% Owner of Mirati Therapeutics Inc and owns about 0 shares of Mirati Therapeutics Inc (MRTX) stock worth over $0. Details can be seen in Tuesday Thirteen Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tuesday Thirteen Inc. has not made any transactions after 2017-09-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tuesday Thirteen Inc.
Tuesday Thirteen Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tuesday Thirteen Inc. owns 2 companies in total, including Esperion Therapeutics Inc (ESPR) , and Mirati Therapeutics Inc (MRTX) .
Click here to see the complete history of Tuesday Thirteen Inc.’s form 4 insider trades.
Insider Ownership Summary of Tuesday Thirteen Inc.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ESPR | Esperion Therapeutics Inc | 2018-10-26 | 10 percent owner |
MRTX | Mirati Therapeutics Inc | 2017-09-21 | 10 percent owner |
Tuesday Thirteen Inc. Latest Holdings Summary
Tuesday Thirteen Inc. currently owns a total of 1 stock. Tuesday Thirteen Inc. owns 0 shares of Mirati Therapeutics Inc (MRTX) as of September 21, 2017, with a value of $0.
Latest Holdings of Tuesday Thirteen Inc.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MRTX | Mirati Therapeutics Inc | 2017-09-21 | 0 | 58.70 | 0 |
Holding Weightings of Tuesday Thirteen Inc.
Tuesday Thirteen Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Tuesday Thirteen Inc. has made a total of 0 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years. The most-recent trade in Mirati Therapeutics Inc is the sale of 1,000 shares on September 21, 2017, which brought Tuesday Thirteen Inc. around $10,650.
Insider Trading History of Tuesday Thirteen Inc.
- 1
Tuesday Thirteen Inc. Trading Performance
Tuesday Thirteen Inc. Ownership Network
Tuesday Thirteen Inc. Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Tuesday Thirteen Inc. is the 10 percent owner of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Operating Officer Sheldon L. Koenig , Chief Commercial Officer Eric Warren , and Chief Medical Officer Joanne M. Foody .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Tuesday Thirteen Inc. made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,687 shares made by Eric Warren , a net sale of 5,140 shares made by Joanne M. Foody , and a net purchase of 5,450 shares made by Sheldon L. Koenig .
In summary, during the past 3 months, insiders sold 18,394 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 18,394 shares. During the past 18 months, 28,667 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 30,944 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Tuesday Thirteen Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Tuesday Thirteen Inc.. You might contact Tuesday Thirteen Inc. via mailing address: Cay House, Ep Taylor Drive, Lyford Cay, New Providence C5 N7776.